Gemtuzumab ozogamicin (Mylotarg) monotherapy for relapsed AML after hematopoietic stem cell transplant: efficacy and incidence of hepatic veno-occlusive disease - Cohen,A.D.; Luger,S.M.; Sickles,C. (Bone Marrow Transplant, 2002)